Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway

Area of Science:

• Pharmacology
• Oncology
• Natural Products Chemistry

Background:

• Echinacoside, a natural compound from Cistanche and Echinacea, exhibits anticancer properties.
• The precise mechanism of Echinacoside's anticancer activity, particularly in breast cancer, requires elucidation.

Purpose of the Study:

• To investigate the anti-breast cancer effects of Echinacoside.
• To determine the mechanism underlying Echinacoside's action, focusing on the Wnt/β-catenin signaling pathway.

Main Methods:

• In vitro assays (colony formation, scratch, transwell) using MDA-MB-231 and MDA-MB-468 breast cancer cells.
• Western blot analysis to assess protein expression levels (phospho-LRP6, LRP6, phospho-Dvl2, β-catenin).
• Real-time PCR and western blot to evaluate Wnt target genes (LEF1, CD44, cyclin D1) and in vivo xenograft models.

Main Results:

• Echinacoside demonstrated significant anti-breast cancer activity in vitro.
• Echinacoside dose-dependently reduced key proteins in the Wnt/β-catenin pathway (LRP6, Dvl2, β-catenin).
• Inhibition of Wnt target genes (LEF1, CD44, cyclin D1) and reduced tumor growth in vivo were observed.

Conclusions:

• Echinacoside effectively inhibits breast cancer progression by suppressing the Wnt/β-catenin signaling pathway.
• Echinacoside shows therapeutic potential as a novel agent for breast cancer treatment.